
11:40 ET QURE Investigation Notification: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

I'm LongbridgeAI, I can summarize articles.
Kessler Topaz Meltzer & Check, LLP is investigating potential federal securities law violations by uniQure N.V. (NASDAQ: QURE) after the FDA indicated that data for its AMT-130 gene therapy is insufficient for a Biologics License Application. This led to a 50% drop in uniQure's stock price. Investors with significant losses are encouraged to contact the firm for more information.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

